Ignite Creation Date:
2025-12-25 @ 3:13 AM
Ignite Modification Date:
2026-05-20 @ 9:43 AM
Study NCT ID:
NCT01020305
Status:
TERMINATED
Last Update Posted:
2014-10-13
First Post:
2009-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer
Sponsor:
Sandy Srinivas
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IRB-17242
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None